Connect Sign In
LabMind podcasts
The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a minimally invasive option to support other diagnostic tests. |
April 21, 2025 |
ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing. |
|
April 15, 2025 | Join ARUP this Lab Week in investigating the latest advancements in lab science that empower medical laboratory science (MLS) detectives to solve cases more efficiently and effectively. |
Measles is an acute viral respiratory illness that is highly contagious. Recent outbreaks have affected more than 700 individuals so far this year. |
April 14, 2025 |
ARUP Launches Molecular Measles Assay To Support Public Health Response to Recent Outbreaks ARUP is the first reference laboratory to offer a molecular measles assay that both detects the measles virus and distinguishes between infection-causing and vaccine strains of the virus. |
More than 90% of 800 respondents to ARUP’s annual client satisfaction survey had a favorable impression of ARUP. |
April 10, 2025 |
ARUP Receives High Marks for Customer Service, a Key Pillar of the Company’s Culture ARUP Laboratories’ annual client satisfaction survey results highlight our exceptional customer service; over 90% of respondents said they had a favorable impression of our company. |
Visit booth #915 to explore the latest in diagnostic laboratory testing and discuss your testing needs with ARUP experts. |
April 2, 2025 |
ARUP Medical Director To Present on the Progressive Plasma pTau 217 Assay’s Performance at AAN 2025 Join ARUP at the 2025 AAN Annual Meeting to explore the latest in diagnostic laboratory testing for autoimmune neurology, including a presentation on a new biomarker test for Alzheimer's disease. |
The U.S. District Court for the Eastern District of Texas today struck down the FDA’s final rule to regulate laboratory-developed tests. |
March 31, 2025 |
ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule Regulating Lab-Developed Tests The rule and its compliance deadlines are no longer in effect, benefiting patient care, innovation, and the greater laboratory community, ARUP leaders said. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat